TARGET-BREAST · Breast cancer biomarkers and functional mediators: Harnessing the new wealth of -omic data

Lines connect the coordinator with its partners. CORDIS does not always give exact coordinates for projects before 2014. These points are placed at city or country level.

Project objective

Breast cancer is a disease that presents great emotional, social, economical and clinical problems in Europe and the world in general. There is a crucial need to develop more targeted therapies and marker systems for breast cancer. In this ToK Programme, we plan to harness the wealth of transcriptomic and other -omic data emerging from molecular analysis of human breast tumours.The ToK Programme will provide advanced training to Experienced Researchers, as well as exchange unique skills between academic and industrial sectors, in the areas of transcriptomic and bioinformatic analysis, along with tissue microarray and RNA interference technologies. This project displays significant interplay between basic and clinical science. Crucially, this project will utilise an effective combination of computational and wet-lab procedures to meet its aims.The current consortium brings together 6 participant institutions from academic and industrial sectors across 4 EU countries. The work activities detailed in this proposal are likely to have a significant impact on the development of novel diagnostics and therapeutics for breast cancer, a disease which primarily afflicts women.

Original text from CORDIS.

Participants

• NATIONAL UNIVERSITY OF IRELAND, DUBLIN · DUBLINCoordinatorIreland
• AGENDIA BV · AMSTERDAMCity levelNetherlands
• LUNDS UNIVERSITET · LUNDSweden
• SLIDEPATH LTD. · DUBLIN 9City levelIreland
• VERENIGING HET NEDERLANDS KANKERINSTITUUT · AMSTERDAMCity levelNetherlands

Links

• View on CORDIS